233 related articles for article (PubMed ID: 35936217)
21. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
[TBL] [Abstract][Full Text] [Related]
22. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis.
Lasek-Bal A; Jedrzejowska-Szypulka H; Student S; Warsz-Wianecka A; Zareba K; Puz P; Bal W; Pawletko K; Lewin-Kowalik J
J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31356182
[TBL] [Abstract][Full Text] [Related]
23. National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke.
Chalos V; van der Ende NAM; Lingsma HF; Mulder MJHL; Venema E; Dijkland SA; Berkhemer OA; Yoo AJ; Broderick JP; Palesch YY; Yeatts SD; Roos YBWEM; van Oostenbrugge RJ; van Zwam WH; Majoie CBLM; van der Lugt A; Roozenbeek B; Dippel DWJ;
Stroke; 2020 Jan; 51(1):282-290. PubMed ID: 31795895
[TBL] [Abstract][Full Text] [Related]
24. DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke.
Diener HC; Schneider D; Lampl Y; Bornstein NM; Kozak A; Rosenberg G
Stroke; 2008 Jun; 39(6):1774-8. PubMed ID: 18403736
[TBL] [Abstract][Full Text] [Related]
25. AMPA antagonist ZK200775 in patients with acute ischemic stroke: possible glial cell toxicity detected by monitoring of S-100B serum levels.
Elting JW; Sulter GA; Kaste M; Lees KR; Diener HC; Hommel M; Versavel M; Teelken AW; De Keyser J
Stroke; 2002 Dec; 33(12):2813-8. PubMed ID: 12468775
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Selenium Supplementation in Acute Ischemic Stroke Outcome: An Outcome Assessor Blind, Randomized, Placebo-Controlled, Feasibility Study.
Sharifi-Razavi A; Karimi N; Jafarpour H
Neurol India; 2022; 70(1):87-93. PubMed ID: 35263859
[TBL] [Abstract][Full Text] [Related]
27. The significance of the oxidative stress markers in the one-year prognosis of patients with acute ischemic stroke: a case-control study.
Shaafi S; Hadisi F; Mahmoudinezhad M; Razmi H; Nejadghaderi SA; Khalili M
BMC Neurol; 2021 Jul; 21(1):258. PubMed ID: 34215195
[TBL] [Abstract][Full Text] [Related]
28. [A panel of serum biomarkers, including damage, apoptosis and neurotrophic markers, for the assessment of prognosis of the course of ischemic stroke].
Chukanova AS; Gulieva MS; Chukanova EI; Bagmanyan SJ
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(8. Vyp. 2):48-53. PubMed ID: 36036143
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (LUCENT): study protocol for a multicenter randomized controlled trial.
Chen Y; Liu Y; Zhang J; Zhou K; Zhang X; Dai H; Yang B; Shang H
Trials; 2022 Apr; 23(1):285. PubMed ID: 35410433
[TBL] [Abstract][Full Text] [Related]
30. Effects of dietary α-lipoic acid, acetyl-l-carnitine, and sex on antioxidative ability, energy, and lipid metabolism in broilers.
Jia R; Bao YH; Zhang Y; Ji C; Zhao LH; Zhang JY; Gao CQ; Ma QG
Poult Sci; 2014 Nov; 93(11):2809-17. PubMed ID: 25239530
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of modulatory effects of saffron (
Gudarzi S; Jafari M; Pirzad Jahromi G; Eshrati R; Asadollahi M; Nikdokht P
Nutr Neurosci; 2022 Jun; 25(6):1137-1146. PubMed ID: 33151132
[TBL] [Abstract][Full Text] [Related]
32. Safety and outcomes of endovascular treatment in patients with very severe acute ischemic stroke.
Bala F; Bricout N; Nouri N; Cordonnier C; Henon H; Casolla B
J Neurol; 2022 May; 269(5):2493-2502. PubMed ID: 34618225
[TBL] [Abstract][Full Text] [Related]
33. The effects of L-carnitine supplementation on inflammatory factors, oxidative stress, and clinical outcomes in patients with sepsis admitted to the intensive care unit (ICU): study protocol for a double blind, randomized, placebo-controlled clinical trial.
Keshani M; Alikiaii B; Askari G; Yahyapoor F; Ferns GA; Bagherniya M
Trials; 2022 Feb; 23(1):170. PubMed ID: 35193654
[TBL] [Abstract][Full Text] [Related]
34. Association between Baseline NIHSS Limb Motor Score and Functional Recovery after Stroke: Analysis Based on a Multicountry Dataset.
Chen CLH; Pokharkar Y; Venketasubramanian N;
Cerebrovasc Dis; 2023; 52(2):160-165. PubMed ID: 35908546
[TBL] [Abstract][Full Text] [Related]
35. Defining mild stroke: outcomes analysis of treated and untreated mild stroke patients.
Spokoyny I; Raman R; Ernstrom K; Khatri P; Meyer DM; Hemmen TM; Meyer BC
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1276-81. PubMed ID: 25906938
[TBL] [Abstract][Full Text] [Related]
36. Coenzyme Q10 supplementation in acute ischemic stroke: Is it beneficial in short-term administration?
Ramezani M; Sahraei Z; Simani L; Heydari K; Shahidi F
Nutr Neurosci; 2020 Aug; 23(8):640-645. PubMed ID: 30404563
[No Abstract] [Full Text] [Related]
37. Rehabilitation Training Can Significantly Increase the Serum IL-11 Levels and Improve the Prognosis in Ischemic Stroke Patients.
Li X; Zhang J; Wang Q; Xiang L; Dong J
Mediators Inflamm; 2023; 2023():1865760. PubMed ID: 36875689
[TBL] [Abstract][Full Text] [Related]
38. RECAST (Remote Ischemic Conditioning After Stroke Trial): A Pilot Randomized Placebo Controlled Phase II Trial in Acute Ischemic Stroke.
England TJ; Hedstrom A; O'Sullivan S; Donnelly R; Barrett DA; Sarmad S; Sprigg N; Bath PM
Stroke; 2017 May; 48(5):1412-1415. PubMed ID: 28265014
[TBL] [Abstract][Full Text] [Related]
39. Hyper-acute EEG alterations predict functional and morphological outcomes in thrombolysis-treated ischemic stroke: a wireless EEG study.
Ajčević M; Furlanis G; Naccarato M; Miladinović A; Buoite Stella A; Caruso P; Cillotto T; Accardo A; Manganotti P
Med Biol Eng Comput; 2021 Jan; 59(1):121-129. PubMed ID: 33274407
[TBL] [Abstract][Full Text] [Related]
40. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
